Effects of brain natriuretic peptide on forearm vasculature: Comparison with atrial natriuretic peptide

Cardiovascular Research

Volumn 44, Issue 3, 1999, Pages 595-600

  Van Der Zander, Kim ^a   Houben, Alphons J H M ^a   Kroon, Abraham A ^a   De Leeuw, Peter W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood flow; Hemodynamics; Hormones; Natriuretic peptide; Vasoconstriction dilation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR AFFINITY; REPRODUCIBILITY; VASOCONSTRICTION; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; VOLUNTEER;

ADULT; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; LINEAR MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; VASODILATION;

EID: 0033437208     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00234-5     Document Type: Article

References (32)

1. Ogawa Y, Nakao K, Mukoyama M et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats; the ventricle is the major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
2. Lang CC, Choy AMJ, Turner K et al. The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. J Hypertens 1993;11:737-741.
3. Nishikimi T, Yoshihara F, Morimoto A et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
4. Takeda T, Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res 1995;18:259-266.
5. Holmes SJ, Espiner EA, Richards AM, Yandle TG. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-96.
6. Yoshimura M, Yasue H, Morita E et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-1588.
7. McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990;70:1103-1107.
8. Lazzeri C, Franchi F, Porciani C et al. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. Am J Hypertens 1995;8:799-807.
9. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86:1081-1088.
10. Bennet BD, Bennet GL, Vitangcol RV et al. Extracellular domain-IgG infusion proteins for three human natriuretic peptide receptors. J Biol Chem 1991;266:23060-23067.
11. World Medical Association. Declaration of Helsinki. Recommenda-tions guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-3.
12. Branten AJ, Smits P, Janssen TL, Wollersheim H, Thien T. Effect of atrial natriuretic peptide on skin microcirculation versus skeletal muscle blood flow. J Cardiovasc Pharmacol 1996;27:303-306.
13. Houben AJHM, Schaper NC, de Haan CHA et al. Local 24-h hyperglycaemia does not affect endothelium-dependent or -independent vasoreactivity in humans. Am J Physiol 1996;270:H2014-H2020.
14. Houben AJHM, Slaaf DW, Huvers FC et al. Diurnal variations in total forearm and skin microcirculatory blood flow in man. Scan J Clin Lab Invest 1994;54:161-169.
15. Benjamin N, Calver A, Collier J et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-923.
16. Bruning TA, Kemme MJ, Chang PC, Muizert Y, van Zwieten PA. Calculation of plasma concentrations of intra-arterially infused compounds in forearm plethysmography. Cardiovasc Res 1998;37:210-215.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986:307-311.
18. Protter AA, Wallace AM, Ferraris VA, Weishaar RE. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 1996;9:432-436.
19. Nakamura M, Arakawa N, Yoshida H et al. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J 1998;135:414-420.
20. Anand-Srivastava MB. Atrial natriuretic peptide-C receptor and membrane signalling in hypertension. J Hypertens 1997;15:815-826.
21. Hempel A, Noll T, Bach C et al. Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability. Am J Physiol 1998;275:H1818-1825.
22. Kubo M, Nakaya Y, Matsuoka S, Saito K, Kuroda Y. Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. Circ Res 1994;74:471-476.
23. Price JM, Hellermann A. Inhibition of cGMP mediated relaxation in small rat coronary arteries by block of Ca2+ activated K+ channels. Life Sci 1997;61:1185-1192.
24. Gelfand RA, Frank HJL, Levin E, Pedram A. Brain and atrial natriuretic peptides bind to common receptors in brain capillary endothelial cells. Am J Physiol 1991;261:E183-189.
25. Emori T, Hirata Y, Imai T et al. Cellular mechanisms of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 1993;133:2474-2480.
26. Nazario B, Hu R-M, Pedram A, Prins B, Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest 1995;95:1151-1157.
27. Moritoki H, Yoshikawa T, Hisayama T, Takeuchi S. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide. Eur J Pharmacol 1992;210:61-68.
28. Houben AJHM, Krekels MME, Schaper NC et al. Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet. Cardiovasc Res 1998;39:442-450.
29. Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990;70:665-695.
30. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991;87:1402-1412.
31. LaVilla G, Vena S, Conti A et al. Plasma levels of brain natriuretic peptide in healthy subjects and patients with essential hypertension: Response to posture. Clin Sci 1993;85:411-416.
32. Buckley M, Sethi D, Markandu N et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci 1992;82:127-131.